Arcadia Biosciences to Present at The Spring Investor Summit April 1-2, 2019

Arcadia Biosciences, Inc. announced that it will be featured as a presenting company at The Spring Investor Summit.

March 26, 2019 12:00 UTC

DAVIS, Calif.--(BUSINESS WIRE)-- Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural food ingredient company and proven leader in improving the quality and nutritional content of crops, today announced that it will be featured as a presenting company at The Spring Investor Summit. The conference is being held April 1-2 at the Essex House in New York City.

Raj Ketkar, Arcadia’s president and CEO, will present a business overview at 1:00 p.m. EDT on Tuesday, April 2, 2019, and will be available for meetings with investors. Attendees may schedule a meeting by logging into the conference website at www.springinvestorsummit.

A webcast of the presentation and Arcadia’s investor handout will be available in the Investors section of the company’s website.

About Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc. (Nasdaq: RKDA) develops and markets high-value food ingredients and nutritional oils that help meet consumer demand for a healthier diet. Arcadia’s GoodWheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. The company’s agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. For more information, visit www.arcadiabio.com.

About The Spring Investor Summit

The Spring Investor Summit (formerly The MicroCap Conference) is an exclusive event dedicated to connecting small and micro cap companies with high-level, institutional and retail investors.

The upcoming conference will feature 200 presenting companies, 1200 institutional and retail investors, 2000 one-on-one meetings, expert speakers, and industry panels. For registration, please visit www.springinvestorsummit.

Contacts

Jeff Bergau
jeff.bergau@arcadiabio.com
+1-312-217-0419

Source: Arcadia Biosciences, Inc.

MORE ON THIS TOPIC